Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer

NCT03021993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Oral Cavity SCC

Interventions

DRUG: Nivolumab

Sponsor

Medical University of South Carolina

Collaborators

[object Object]